Krux
March 30, 2026
Doctronic Raises $40M After AI Legally Renews Prescriptions
Published: March 30, 2026 at 1:47 AM
Updated: March 30, 2026 at 1:47 AM
100-word summary
Doctronic just closed a $40 million Series B, its third round in under a year, after becoming the first AI allowed to autonomously renew prescriptions in the U.S. through Utah's regulatory sandbox. Abstract and Lightspeed co-led the round. The company hit 300,000 weekly users and 15× revenue growth within six months of its Series A. Now it's targeting hospital systems, insurance networks, and pediatrics. The real story? Investors are betting that if you can navigate healthcare regulation once, the moat compounds. Utah cracked the door open. The money suggests Doctronic plans to walk through it in every state that will let them.
What happened
Doctronic just closed a $40 million Series B, its third round in under a year, after becoming the first AI allowed to autonomously renew prescriptions in the U.S. through Utah's regulatory sandbox. Abstract and Lightspeed co-led the round.
Why it matters
The company hit 300,000 weekly users and 15× revenue growth within six months of its Series A. Now it's targeting hospital systems, insurance networks, and pediatrics. The real story? Investors are betting that if you can navigate healthcare regulation once, the moat compounds. Utah cracked the door open. The money suggests Doctronic plans to walk through it in every state that will let them.